Вы находитесь на странице: 1из 18

To Enquire About

the Report Click


Here

IndustryARC

Global Computational Medicine and Drug Discovery Software


Market Analysis and Forecast (2014-2020)

By Tools (Software, Databases and Others); By Application (Drug Discovery and


Development, Disease Modeling, Medical Imaging and Others) & By Geography

To Enquire About
the Report Click
Here

Table of Contents
1. Global Computational Medicine and Drug Discovery Software Market Overview
2. Executive Summary
3. Global Computational Medicine and Drug Discovery Software Market Landscape
3.1. Market share Analysis
3.2. Comparative Analysis
3.2.1.

Product Benchmarking

3.2.2.

End-User Profiling

3.2.3.

Patent Analysis

3.2.4.

Top 5 Financial Analysis

4. Global Computational Medicine and Drug Discovery Software - Market Forces

4.1. Market Drivers


4.2. Market Constraints
4.3. Market Challenges
4.4. Attractiveness of the Industry
4.4.1.

Power of Suppliers

4.4.2.

Power of Customers

4.4.3.

Threat of New entrants

4.4.4.

Threat of Substitution

4.4.5.

Degree of Competition

5. Global Computational Medicine and Drug Discovery Software Market Strategic Analysis
5.1. Value Chain Analysis
5.2. Pricing Analysis
5.3. Opportunity Analysis

To Enquire About
the Report Click
Here

5.4. Product Life Cycle Analysis


5.5. Suppliers & Distributors
6. Global Computational Medicine and Drug Discovery Software Market By Tools
6.1. Introduction
6.2. Databases
6.3. Software
6.4. Others
7. Global Computational Medicine and Drug Discovery Software Market By Application
7.1. Introduction
7.2. Computational Physiological Medicine
7.3. Drug Discovery and Development
7.4. Medical Imaging
7.5. Disease Modelling
7.6. Predictive Analysis of Drug Targets
7.7. Cellular Simulation
7.8. Simulation Software
7.9. Others
8. Global Computational Medicine and Drug Discovery Software Market By Geography
8.1. Introduction
8.2. North America
8.2.1.

U.S.

8.2.2.

Canada

8.3. Europe
8.3.1.

U.K.

To Enquire About
the Report Click
Here

8.3.2.

Germany

8.3.3.

Netherlands

8.3.4.

Norway

8.3.5.

Italy

8.3.6.

Others

8.4. APAC
8.4.1.

China

8.4.2.

Japan

8.4.3.

Korea

8.4.4.

Australia

8.4.5.

Others

8.5. RoW
9. Market Entropy
9.1. New Product Launches
9.2. M&As, Collaborations, Partnerships & JVs
10. Investment Opportunities
11. Company Profiles
11.1.

Aurora Fine Chemicals LLC

11.2.

Biognos AB

11.3.

Certara, L.P.

11.4.

Chemical Computing Group Inc.

11.5.

CLC bio

11.6.

Collaborative Drug Discovery, Inc.

11.7.

Compugen Ltd.

To Enquire About
the Report Click
Here

11.8.

Crown Bioscience Inc.

11.9.

Dassault Systemes, BIOVIA Corp.

11.10. Domainex Ltd


11.11. Entelos, Inc.
11.12. Genedata AG
11.13. Leadscope, Inc.
11.14. Nimbus Therapeutics
11.15. Prosarix Ltd
11.16. Quant Med LLC
11.17. Quantum Pharmaceuticals
11.18. Rhenovia Pharma Limited
11.19. Simulations Plus, Inc.
11.20. Schrdinger, LLC
12. Appendix
12.1.

Abbreviations

12.2.

Sources

12.3.

Research Methodology

12.4.

Bibliography

12.5.

Compilation of Expert Insights

12.6.

Disclaimer

To Enquire About
the Report Click
Here

LIST OF TABLES
Table 1 Product Benchmarking for Global Computational Medicine and Drug Discovery Software
Market By Software ($)
Table 2 Global Computational Medicine and Drug Discovery Software Market Pricing Analysis
($)
Table 3 Global Computational Medicine and Drug Discovery Software Market Revenue, By Tools,
2014-2020 ($M)
Table 4 Global Computational Medicine and Drug Discovery Software Market Revenue, By
Databases, By Application, 2014-2020 ($M)
Table 5 Global Computational Medicine and Drug Discovery Software Market Revenue, By
Databases, By Geography, 2014-2020 ($M)
Table 6 Global Computational Medicine and Drug Discovery Software Market Revenue, By
Software, By Application, 2014-2020 ($M)
Table 7 Global Computational Medicine and Drug Discovery Software Market Revenue, By
Software, By Geography, 2014-2020 ($M)
Table 8 Global Computational Medicine and Drug Discovery Software Market Revenue, By Other
Tools, By Application, 2014-2020 ($M)
Table 9 Global Computational Medicine and Drug Discovery Software Market Revenue, By Other
Tools, By Geography, 2014-2020 ($M)
Table 10 Global Computational Medicine and Drug Discovery Software Market Revenue, By
Application, 2014-2020 ($M)
Table 11 Global Computational Medicine and Drug Discovery Software Market Revenue in
Computational Physiological Medicine, By Tools, 2014-2020 ($M)
Table 12 Global Computational Medicine and Drug Discovery Software Market Revenue in
Computational Physiological Medicine, By Geography, 2014-2020 ($M)
Table 13 Global Computational Medicine and Drug Discovery Software Market Revenue in Drug
Discovery and Development, By Tools, 2014-2020 ($M)
Table 14 Global Computational Medicine and Drug Discovery Software Market Revenue in Drug
Discovery and Development, By Geography, 2014-2020 ($M)
Table 15 Global Computational Medicine and Drug Discovery Software Market Revenue in
Medical Imaging, By Tools, 2014-2020 ($M)

To Enquire About
the Report Click
Here

Table 16 Global Computational Medicine and Drug Discovery Software Market Revenue in
Medical Imaging, By Geography, 2014-2020 ($M)
Table 17 Global Computational Medicine and Drug Discovery Software Market Revenue in
Disease Modelling, By Tools, 2014-2020 ($M)
Table 18 Global Computational Medicine and Drug Discovery Software Market Revenue in
Disease Modelling, By Geography, 2014-2020 ($M)
Table 19 Global Computational Medicine and Drug Discovery Software Market Revenue in
Predictive Analysis of Drug Targets, By Tools, 2014-2020 ($M)
Table 20 Global Computational Medicine and Drug Discovery Software Market Revenue in
Predictive Analysis of Drug Targets, By Geography, 2014-2020 ($M)
Table 21 Global Computational Medicine and Drug Discovery Software Market Revenue in
Cellular Simulation, By Tools, 2014-2020 ($M)
Table 22 Global Computational Medicine and Drug Discovery Software Market Revenue in
Cellular Simulation, By Geography, 2014-2020 ($M)
Table 23 Global Computational Medicine and Drug Discovery Software Market Revenue in
Simulation Software, By Tools, 2014-2020 ($M)
Table 24 Global Computational Medicine and Drug Discovery Software Market Revenue in
Simulation Software, By Geography, 2014-2020 ($M)
Table 25 Global Computational Medicine and Drug Discovery Software Market Revenue in Other
Applications, By Tools, 2014-2020 ($M)
Table 26 Global Computational Medicine and Drug Discovery Software Market Revenue in Other
Applications, By Geography, 2014-2020 ($M)
Table 27 Global Computational Medicine and Drug Discovery Software Market, By Geography,
2014-2020 ($M)
Table 28 North America: Computational Medicine and Drug Discovery Software Market Revenue,
By Country, 2014-2020 ($M)
Table 29 North America: Computational Medicine and Drug Discovery Software Market Revenue,
By Tools, 2014-2020 ($M)
Table 30 North America: Computational Medicine and Drug Discovery Software Market Revenue,
By Application, 2014-2020 ($M)
Table 31 Europe: Computational Medicine and Drug Discovery Software Market Revenue, By
Country, 2014-2020 ($M)

To Enquire About
the Report Click
Here

Table 32 Europe: Computational Medicine and Drug Discovery Software Market Revenue, By
Tools, 2014-2020 ($M)
Table 33 Europe: Computational Medicine and Drug Discovery Software Market Revenue, By
Application, 2014-2020 ($M)
Table 34 APAC: Computational Medicine and Drug Discovery Software Market Revenue, By
Country, 2014-2020 ($M)
Table 35 APAC: Computational Medicine and Drug Discovery Software Market Revenue, By
Tools, 2014-2020 ($M)
Table 36 APAC: Computational Medicine and Drug Discovery Software Market Revenue, By
Application, 2014-2020 ($M)
Table 37 RoW: Computational Medicine and Drug Discovery Software Market Revenue, By
Country, 2014-2020 ($M)
Table 38 RoW: Computational Medicine and Drug Discovery Software Market Revenue, By Tools,
2014-2020 ($M)
Table 39 RoW: Computational Medicine and Drug Discovery Software Market Revenue, By
Application, 2014-2020 ($M)

To Enquire About
the Report Click
Here

LIST OF FIGURES
Figure1 Global Computational Medicine and Drug Discovery Software Market, By Geography,
2014 - 2020 ($M)
Figure2 Segmentation of Global Computational Medicine and Drug Discovery Software Market
Figure3 Global Computational Medicine and Drug Discovery Software Market Competitive Share
Analysis, 2014(%)
Figure4 Global Computational Medicine and Drug Discovery Software Market Share, By
Application, 2014 (%)
Figure5 Global Computational Medicine and Drug Discovery Software Market Share, By
Geography, 2014 (%)
Figure6 North America Computational Medicine and Drug Discovery Software Market Share, By
Country, 2014 (%)
Figure7 Europe Computational Medicine and Drug Discovery Software Market Share, By Country,
2014 (%)
Figure8 APAC Computational Medicine and Drug Discovery Software Market Share, By Country,
2014 (%)
Figure9 RoW Computational Medicine and Drug Discovery Software Market Share, By Country,
2014 (%)
Figure10 Global Computational Medicine and Drug Discovery Software Market Recent
Developments, By Year, 2012-2015

To Enquire About
the Report Click
Here

1. GLOBAL COMPUTATIONAL MEDICINE AND DRUG


DISCOVERY SOFTWARE MARKET OVERVIEW
1.1 REPORT SCOPE
The global market for Computational Medicine and Drug Discovery Software has been segmented
by the various tools and their applications in life sciences and healthcare. The major applications for
global Computational Medicine and Drug Discovery Software market are found in computational
physiological medicine, drug discovery and development, disease modeling, body simulation
software development, predicting and analyzing specific drug targets and so on. Each of these
segmentations has been studied to give a comprehensive analysis of the global computational
medicine and drug discovery software market.
The overall market has also been presented from the perspective of different geographic locations
into standard geographic regions and key economies for this market. Competitive landscape for each
of the capture technologies and storage methods is highlighted and the market players are profiled
with attributes of company overview, financial overview, business strategies, product portfolio and
recent developments. Market shares of the key players for 2014 are provided. The prominent players
profiled in this report are Compugen Ltd., Certara, L.P., Dassault Systemes BIOVIA Corp.,
Schrdinger, LLC, Genedata AG and others.
The report contains the most detailed and in-depth segmentation and analysis of the global
computational medicine and drug discovery software market during the period 2014 - 2020.

To Enquire About
the Report Click
Here

1.2 Stakeholders
The following are the prominent stakeholders in the global computational medicine and drug
discovery software market.
Healthcare professionals
Chemical and Pharmaceutical experts
IT and Software developers
Bio-informatics professionals
Bio-Technologists and Bio-medical engineers
Universities and R&D institutes
Regulatory authorities
Patients

To Enquire About
the Report Click
Here

2. EXECUTIVE SUMMARY
The computational medicine and drug discovery software market encompasses the use of pharmacy,
chemistry, biotechnology and software knowledge for drug discovery and development. This is
accompanied by development of algorithms and simulation of various models to study the
pharmacokinetics and pharmacodynamics of a particular drug.
The global market for computational medicine and drug discovery software is valued at $X billion in
2014 and is projected to grow with a healthy double digit CAGR of XX% through 2020. Recent
growth in disease modeling, drug designing and development by leveraging various bioinformatics
tools will lead to the market growth during the period under study (2014-2020).

SAMPLE TABLE: GLOBAL COMPUTATIONAL MEDICINE AND DRUG DISCOVERY


SOFTWARE MARKET, BY APPLICATION, 2014-2020 ($M)
Application

2014

2015

Computational
xx
xx
Physiological
Medicine
Drug Discovery and
xx
xx
Development
Medical Imaging
xx
xx
Disease Modeling
xx
xx
Predictive Analysis
xx
xx
of Drug Targets
Cellular Simulation
xx
xx
Simulation Software
xx
xx
Others
xx
xx
Total
xx
xx
Source: IndustryARC Analysis, Expert Insights

2016

2017

2019

2020

CAGR%
(20152020)

xx

xx

xx

xx

xx%

xx

xx

xx

xx

xx%

xx
xx
xx

xx
xx
xx

xx
xx
xx

xx
xx
xx

xx%
xx%
xx%

xx
xx
xx
xx

xx
xx
xx
xx

xx
xx
xx
xx

xx
xx
xx
xx

xx%
xx%
xx%
xx%

As of 2014, the application of computational medicine in simulation of cells is estimated to grow at


the fastest pace, due to the increasing research activities on sequencing of proteins to design and
develop customized medicines suited to an individuals needs. Drug discovery, development and
disease modeling applications occupy the highest market share owing to the widespread drug
development approaches adopted by several major pharmaceutical companies.

To Enquire About
the Report Click
Here

SAMPLE FIGURE: GLOBAL COMPUTATIONAL MEDICINE AND DRUG DISCOVERY


SOFTWARE MARKET, BY REGION, 2014 (%)

North America
Europe
APAC
RoW

Source: IndustryARC Analysis, Expert Insights

The North America, led by the U.S. accounted for the largest market share in the global market for
computational medicine and drug discovery software, occupying over 55% of the revenue in 2014.
The huge market size can be credited to the increasing investments in R&D activities pertaining to
drug discovery and development and disease modeling.

To Enquire About
the Report Click
Here

KEY MARKET INSIGHTS


Disease modelling and Drug discovery applications occupied the highest market share in
2014, in terms of applications, accounting for more than 55% of the total market revenue.
APAC region is poised to witness the fastest market growth during the forecast period, with
an estimated CAGR exceeding 25% owing to the increased R&D spending on
pharmacokinetics and pharmacogenomics studies.
The global market for computational medicine and drug discovery in 2014 is dominated by
the databases, when segmented in terms of tools. However, the software tools are estimated
to growth with the highest CAGR due to the growing usage in drug designing and
modelling.
Certara, L.P., in December, 2014 has launched Muse Invent in Japan, which a molecular
design workflow that empowers researchers to design drugs with novel structures or
scaffolds for individuals requirements.
Schrdinger, Inc. and Tri-Institutional Therapeutics Discovery Institute, Inc. (Tri-I TDI) in
September, 2014 have signed agreements to give access to Schrdingers Small-Molecule
Drug Discovery Suite and two other suites to Tri-I TDIs researchers in order to proceed in
preliminary research towards new therapeutics.

To Enquire About
the Report Click
Here

12.3 RESEARCH METHODOLOGY


The quantitative and qualitative data collected for the global computational medicine and drug
discovery market report is from a combination of secondary and primary sources. Research
interviews were conducted with executives and/or mangers in the key device, software
manufacturers and related organizations. These Key Opinion Leaders (KOLs) were then provided a
questionnaire to gather quantitative and qualitative inputs on their operations, performance,
strategies and views on the overall market, including key developments and trends. Data from
interviews is consolidated, checked for consistency and accuracy, and the final market numbers are
again validated by experts. The global computational medicine and drug discovery market was split
by the tools, applications and geography based on different factors like primary and secondary
sources, understanding of the number of companies operating in each segment and also KOL
insights.
We have used various secondary sources such as directories, articles, white papers, newsletters,
annual reports and paid databases such as OneSource, Hoovers and Factiva to identify and collect
information for extensive commercial study of the global computational medicine and drug
discovery market.
The approach towards finding information regarding the market and forecasting has been quite
extensive. The key players in the market and its value chain were identified through secondary
research and their market opinions were also gathered in a similar way through telephonic interviews
and questionnaires. Interviews with key opinion leaders such as managers and marketing personnel
were used extensively in understanding the need and emergence of computational medicine and
drug discovery market.
We also have extensive database of contacts which were used to conduct primary interviews and
also to get their inputs using questionnaires.

To Enquire About
the Report Click
Here

THE ARC ADVANTAGE


An analytical model lies at the core of our process, ensuring logical consistency throughout
our research. We complement the model with secondary data and interviews with industry
experts to reflect the latest trends. With our final expert validation, we provide you with
only the most accurate and actionable intelligence.

THE ARC PROCESS


Analytical
Method
1. Granular
breakdown of
drivers into
factors
2. Validate all
factors in terms
of their present
impact on the
market
3. Assign weights
to these factors in
terms of their
relevance and
impact on the
market
4. Build the
Analytical Model
ANALYTICAL MODEL

Base Method

1. Get a topdown estimate of


the market
2. Follow it up
with a bottom-up
estimate of the
market
3. Check
forconsistency
and new growth
factors that are
relevant over the
next 10 Years

4. Build the Base


model
BASE MODEL

Consolidation
Method
1. Granular
breakdown of
drivers into
factors
2. Validate all
factors in terms
of their present
impact on the
market.
3. Assign weights
to these factors in
terms of their
relevance and
impact on the
market.
4. Build the
Consolidated
Model

Delphi
Verification
1. Verify the
findings of the
model with
experts from
across the value
chain
2. Verify the
findings with
players across
small and large
enterprises
3. Tweak the
model and add
new factors
4. Finalize the
ARC Model

CONSOLIDATED MODEL

ARC MODEL

To Enquire About
the Report Click
Here

ABOUT US
IndustryARC was started by a group of young, passionate professionals along with extensively
experienced industry veterans across various business segments. Our focus and expertise is
mainly in the field of analytics, market research and consulting. Our singular goal is to provide
accurate and affordable research to our clients.
Our research team has expertise in diverse fields like Automotive, Chemicals,Consumer
Product & Services, Electronics, Food & Beverages, Healthcare etc., However diverse the
expertise maybe, everyone in our team shares one common trait - we love data and we love
providing solutions to clients using that data even more! Seeing your business flourish based
on our solutions and strategy is what we love the most!
IndustryARC publishes more than 30 reports on an annual basis in the mentioned Industries.
Our reports are in-depth and high quality reports that can help decision makers frame better
strategies for their business requirements. These reports can be further customized as per your
needs.
Disclaimer:

The reports sold by IndustryARC are limited publications containing valuable market
information provided to a select group of customers in response to orders.

Our customers acknowledge and agree that any report bought from IndustryARC is for
their own internal use and not for general publication or disclosure to third parties.

Our reports or part of the reports, information contained in the report, cannot be
shared or resold to any other third party.

Disclosure to third parties, usage of data in a public document, article or blog by the
customer can be done with prior permission taken from IndustryARC.

For information regarding permissions and sales, contact:


sales@industryarc.com | sanjay.matthews@industryarc.com

To Enquire About
the Report Click
Here

IndustryARC
+1 614 - 588 - 8538
sales@industryarc.com

Copyright 2015 IndustryARC


All Rights Reserved. This document contains highly confidential information and is the sole
property of IndustryARC. No part of it may be circulated, copied, quoted, or otherwise reproduced
without the approval of IndustryARC.